[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360780-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-360780-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","clinical-machine-learning-model-for-predicting-pathological-complete-response-in-patients-with-esophageal-and-gastroesophageal-junction-adenocarcinoma-after-trimodality-therapy","Clinical Machine Learning Model for Predicting Pathological Complete Response in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma After Trimodality Therapy","","Accurate prediction of pathological complete response (pCR) after preoperative chemoradiation followed by surgery can strengthen clinical decision-making and patient counseling for esophageal and gastroesophageal junction adenocarcinoma. This study builds machine-learning predictive models for pCR using clinical variables in a cohort of 569 patients treated with trimodality therapy at MD Anderson Cancer Center from 2002 to 2022. Results identify factors linked to non-pCR and evaluate multiple ML algorithms, with random forest showing the best discrimination and higher survival in pCR patients.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-machine-learning-model-for-predicting-pathological-complete-response-in-patients-with-esophageal-and-gastroesophageal-junction-adenocarcinoma-after-trimodality-therapy/360780/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-machine-learning-model-for-predicting-pathological-complete-response-in-patients-with-esophageal-and-gastroesophageal-junction-adenocarcinoma-after-trimodality-therapy/360780.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study?","Question",{"text":63,"@type":64},"Develop machine-learning predictive models to estimate pathological complete response (pCR) after trimodality therapy in patients with esophageal and gastroesophageal junction adenocarcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many patients were included, and where were they treated?",{"text":68,"@type":64},"A total of 569 patients treated with trimodality therapy at MD Anderson Cancer Center between 2002 and 2022 were included.",{"name":70,"@type":61,"acceptedAnswer":71},"Which machine learning model showed the best predictive performance for pCR?",{"text":72,"@type":64},"The random forest model demonstrated the highest predictive ability for pCR, with an AUC of 0.702 among the evaluated models.",{"name":74,"@type":61,"acceptedAnswer":75},"What clinical outcomes differed between pCR and non-pCR patients?",{"text":76,"@type":64},"Patients achieving pCR had significantly longer overall survival and relapse-free survival compared with non-pCR patients.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},360780,1790817996,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":119,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[https://doi.org/10.1245/s10434-026-19557-6](https://doi.org/10.1245/s10434-026-19557-6)  \nAnnals of Surgical Oncology (2026) 33:7133–7141  \nORIGINAL ARTICLE THORACIC ONCOLOGY AND ESOPHAGEAL CANCER  \nClinical Machine Learning Model for Predicting Pathological Complete Response in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma After Trimodality Therapy  \nKohei Yamashita, MD1,2 · Evan Kwiatkowski, PhD3 · Matheus Sewastjanow‑Silva, MD1 · Jane E. Rogers, PharmD4 · Katsuhiro Yoshimura, MD1 · Melissa Pool Pizzi, MS1 · Qiong Gan, PhD5 · Jenny J. Li, MD1 · Rebecca E. Waters, DO5 · Mariela Blum Murphy, MD1 · Masaaki Iwatsuki, MD2 · Wayne L. Hofstetter, MD6 · Aileen Chen, MD7 ·  \nYing Yuan, PhD8 · Jaffer A. Ajani, MD1  \nReceived: 6 January 2026 / Accepted: 17 March 2026 / Published online: 19 April 2026 © The Author(s) 2026  \nAbstract  \nBackground Accurate prediction of pathological complete response (pCR) after preoperative chemoradiation therapy, followed by surgery (trimodality therapy) in esophageal adenocarcinoma (EAC) and gastroesophageal junction adenocarcinoma (GEJAC) may improve clinical decision-making and patient counseling before esophagectomy. This study aimed to develop predictive models for pCR after trimodality using machine learning (ML) approaches.  \nPatients and Methods A total of 569 patients with EAC and GEJAC who received trimodality therapy at MD Anderson Cancer Center between 2002 and 2022 were included. Clinicopathological characteristics and survival benefit of patients who achieved a pCR were reviewed via descriptive and survival analyses. Subsequently, ML models based on clinical variables were employed to predict pCR, including BART, random forest, and XGBoost, logistic regression, and LASSO.  \nResults pCR was achieved in 132 patients (23.2%) . Poorly differentiated tumors, tumors with signet ring cell component, higher T stage, higher clinical stage, residual tumor on biopsy after chemoradiation, and higher SUVmax on positron emission tomography-contract tomography (PET-CT) after chemoradiation were significantly associated with non-pCR. pCR patients had significantly longer overall survival (OS) and relapse free survival (RFS) compared with non-pCR patients (median OS, 10.40 versus 4.42 years, log-rank p = 0.0041; median RFS, 10.40 versus 2.35 years, log-rank p \u003C 0.0001) . The random forest model showed the highest predictive ability for pCR with an AUC value of 0.702 among the employed models. Conclusions This first exploratory study supports the validity and potential utility of ML-based models for predicting pCR after trimodality therapy in EAC and GEJAC. Further validation is warranted before clinical application.  \nKohei Yamashita and Evan Kwiatkowski have contributed equally to this work.  \n* Jaffer A. Ajani, MD [jajani@mdanderson.org](jajani@mdanderson.org)  \n1 Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX  \n2 Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan  \n3 Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Houston, TX  \n4 Department of Pharmacy Clinical Programs, University of Texas MD Anderson Cancer Center, Houston, TX  \n5 Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX  \n6 Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX  \n7 Department of Thoracic Radiation Oncology and Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX  \n8 Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX  \nEsophageal and gastroesophageal junction cancers represent a major global health burden, with the seventh highest cancer prevalence and sixth leading cause of cancer-related death in 2020.1 The incidence of esophageal cancer varies geographically betwee","cbCaitoTZ7L9RZxD","https://ap.wps.com/l/cbCaitoTZ7L9RZxD","pdf",777687,"English","# Abstract\n## Background\n## Patients and Methods\n## Results\n## Conclusions\n# Study Context and Rationale\n## Disease burden and epidemiology\n## Treatment approach and relevance of pCR\n## Prior predictors and study limitations\n## Need for improved predictive models","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"Develop machine-learning predictive models to estimate pathological complete response (pCR) after trimodality therapy in patients with esophageal and gastroesophageal junction adenocarcinoma.\"},{\"question\":\"How many patients were included, and where were they treated?\",\"answer\":\"A total of 569 patients treated with trimodality therapy at MD Anderson Cancer Center between 2002 and 2022 were included.\"},{\"question\":\"Which machine learning model showed the best predictive performance for pCR?\",\"answer\":\"The random forest model demonstrated the highest predictive ability for pCR, with an AUC of 0.702 among the evaluated models.\"},{\"question\":\"What clinical outcomes differed between pCR and non-pCR patients?\",\"answer\":\"Patients achieving pCR had significantly longer overall survival and relapse-free survival compared with non-pCR patients.\"}]","Clinical Machine Learning Model for Predicting Pathological Complete Response in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma After Trimodality Therapy | PDF",1790141542,23,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d77a8befe4da6806b64fbb67410ec8c.webp",983,1305,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a63d8c5c0ab85882678614e1e2330674.webp",982,1304,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5220433db82025953b85986cc32dc582.webp",981,1303,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eac49f05df18a65754393693b7ea49a1.webp",980,1301]